Ophthalmology Advisor

Bispecific Antibody Therapeutic Shows Durability in Neovascular AMD

In a phase 2a clinical trial, investigators evaluated the safety of intravitreal VIS-101 in patients with neovascular AMD.
Ophthalmology Advisor

Children, Open Globe Repair Recipients More Likely to Experience Endophthalmitis

Researchers evaluated the incidence of first-time endophthalmitis in adult and pediatric patients within 1 month of various ...
Ophthalmology Advisor

In Glaucoma, Race and Socioeconomic Disparities Increase Risk of Pressure Spikes

A multicenter study investigated sociodemographic predictors of maximum intraocular pressure and pressure spikes among ...
Ophthalmology Advisor

OCU410 Gene Therapy Well Tolerated, Shows Reduced Geographic Atrophy Growth

Investigators presented 12-month phase 2 data on subretinal OCU410 gene therapy in patients with geographic atrophy.
Ophthalmology Advisor

Prior Intravitreal Injections Increase Risk of Cataract Surgery Complications

Investigators analyzed IRIS Registry data to determine whether previous intravitreal injections affect the safety profile of ...